Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
Q.8 (Alpha)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.122.1 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.122.1 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.3.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.3.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.5.6 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.5.6 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.440NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.440NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.25NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.25NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.23.2 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.23.2 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.104 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.104 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.198NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.198NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
EG.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EG.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BN.1.5.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BN.1.5.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.66NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.66NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.485NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.485NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CP.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CP.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.73NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.73NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.112.2 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.112.2 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.36.21NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.36.21NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.1.23NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.1.23NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.134NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.134NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.39.1.3 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.39.1.3 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BN.1.3.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BN.1.3.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
C.38NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
C.38NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
C.26NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
C.26NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Q.4 (Alpha)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Q.4 (Alpha)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.442NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.442NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
P.1.1 (Gamma)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used